These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 22992875)

  • 41. Correlation of cyclooxygenase-2 and aromatase immunohistochemical expression in invasive ductal carcinoma, ductal carcinoma in situ, and adjacent normal epithelium.
    Oliveira VM; Piato S; Silva MA
    Breast Cancer Res Treat; 2006 Feb; 95(3):235-41. PubMed ID: 16322898
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Expression of androgen receptor and two androgen-induced proteins (apolipoprotein D and pepsinogen C) in ductal carcinoma in situ of the breast.
    Gonzalez LO; Corte MD; Junquera S; Bongera M; Rodriguez JC; Vizoso FJ
    Histopathology; 2007 Jun; 50(7):866-74. PubMed ID: 17543076
    [TBL] [Abstract][Full Text] [Related]  

  • 43. E2F-1: a proliferative marker of breast neoplasia.
    Zhang SY; Liu SC; Al-Saleem LF; Holloran D; Babb J; Guo X; Klein-Szanto AJ
    Cancer Epidemiol Biomarkers Prev; 2000 Apr; 9(4):395-401. PubMed ID: 10794484
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Does thymidine phosphorylase correlate with angiogenesis in intraductal carcinoma of the breast?
    Erkus M; Meteoglu I; Culhaci N; Meydan N; Erdogdu I
    Saudi Med J; 2006 Sep; 27(9):1329-33. PubMed ID: 16951768
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Gene expression profiling of the tumor microenvironment during breast cancer progression.
    Ma XJ; Dahiya S; Richardson E; Erlander M; Sgroi DC
    Breast Cancer Res; 2009; 11(1):R7. PubMed ID: 19187537
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Expression of metalloproteases and their inhibitors by tumor and stromal cells in ductal carcinoma in situ of the breast and their relationship with microinvasive events.
    González LO; González-Reyes S; Junquera S; Marín L; González L; Del Casar JM; González JM; Vizoso F
    J Cancer Res Clin Oncol; 2010 Sep; 136(9):1313-21. PubMed ID: 20127359
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Epithelial periostin expression is correlated with poor survival in patients with invasive breast carcinoma.
    Kim GE; Lee JS; Park MH; Yoon JH
    PLoS One; 2017; 12(11):e0187635. PubMed ID: 29161296
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mammographic density is related to stroma and stromal proteoglycan expression.
    Alowami S; Troup S; Al-Haddad S; Kirkpatrick I; Watson PH
    Breast Cancer Res; 2003; 5(5):R129-35. PubMed ID: 12927043
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Periostin suppression induces decorin secretion leading to reduced breast cancer cell motility and invasion.
    Ishiba T; Nagahara M; Nakagawa T; Sato T; Ishikawa T; Uetake H; Sugihara K; Miki Y; Nakanishi A
    Sci Rep; 2014 Nov; 4():7069. PubMed ID: 25400079
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Extracellular matrix components in breast cancer progression and metastasis.
    Oskarsson T
    Breast; 2013 Aug; 22 Suppl 2():S66-72. PubMed ID: 24074795
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Host response to human breast Invasive Ductal Carcinoma (IDC) as observed by changes in the stromal proteome.
    Reddy LA; Mikesh L; Moskulak C; Harvey J; Sherman N; Zigrino P; Mauch C; Fox JW
    J Proteome Res; 2014 Nov; 13(11):4739-51. PubMed ID: 25244421
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Localization of decorin gene expression in normal human breast tissue and in benign and malignant tumors of the human breast.
    Boström P; Sainio A; Kakko T; Savontaus M; Söderström M; Järveläinen H
    Histochem Cell Biol; 2013 Jan; 139(1):161-71. PubMed ID: 23007289
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Alterations in galectin-3 expression and distribution correlate with breast cancer progression: functional analysis of galectin-3 in breast epithelial-endothelial interactions.
    Shekhar MP; Nangia-Makker P; Tait L; Miller F; Raz A
    Am J Pathol; 2004 Dec; 165(6):1931-41. PubMed ID: 15579437
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tumor-extracellular matrix interactions: Identification of tools associated with breast cancer progression.
    Giussani M; Merlino G; Cappelletti V; Tagliabue E; Daidone MG
    Semin Cancer Biol; 2015 Dec; 35():3-10. PubMed ID: 26416466
    [TBL] [Abstract][Full Text] [Related]  

  • 55. More than matrix: the multifaceted role of decorin in cancer.
    Sofeu Feugaing DD; Götte M; Viola M
    Eur J Cell Biol; 2013 Jan; 92(1):1-11. PubMed ID: 23058688
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Decorin protein core affects the global gene expression profile of the tumor microenvironment in a triple-negative orthotopic breast carcinoma xenograft model.
    Buraschi S; Neill T; Owens RT; Iniguez LA; Purkins G; Vadigepalli R; Evans B; Schaefer L; Peiper SC; Wang ZX; Iozzo RV
    PLoS One; 2012; 7(9):e45559. PubMed ID: 23029096
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Human breast cancer invasion and aggression correlates with ECM stiffening and immune cell infiltration.
    Acerbi I; Cassereau L; Dean I; Shi Q; Au A; Park C; Chen YY; Liphardt J; Hwang ES; Weaver VM
    Integr Biol (Camb); 2015 Oct; 7(10):1120-34. PubMed ID: 25959051
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Stromal immunoglobulin κC expression is associated with initiation of breast cancer in TA2 mice and human breast cancer.
    Zhang S; Fei F; Wang H; Gu Y; Li C; Wang X; Zhao Y; Li Y
    Cancer Sci; 2018 Jun; 109(6):1825-1833. PubMed ID: 29683229
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Transition to invasive breast cancer is associated with progressive changes in the structure and composition of tumor stroma.
    Risom T; Glass DR; Averbukh I; Liu CC; Baranski A; Kagel A; McCaffrey EF; Greenwald NF; Rivero-Gutiérrez B; Strand SH; Varma S; Kong A; Keren L; Srivastava S; Zhu C; Khair Z; Veis DJ; Deschryver K; Vennam S; Maley C; Hwang ES; Marks JR; Bendall SC; Colditz GA; West RB; Angelo M
    Cell; 2022 Jan; 185(2):299-310.e18. PubMed ID: 35063072
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Molecular profiling of microinvasive breast cancer microenvironment progression.
    Lessi F; Scatena C; Aretini P; Menicagli M; Franceschi S; Naccarato AG; Mazzanti CM
    J Transl Med; 2019 Jun; 17(1):187. PubMed ID: 31159827
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.